logo ininstituto Cajal

Inicio

linea

Español

linea

English

   
 
Es tiempo de investigaci⊐D17Fn, es tiempo de vida, ....es tiempo de CSIC

biblioteca cajal

Cómo llegar al instituto Cajal

legado Cajal

biblioteca cajal

  Acceso a intranet
 

Intranet CSIC
Intranet Cajal

 

banner Cajal

Departamentos > Neurobiología Funcional y de Sistemas > Neurobiología de los ganglios basales> Publicaciones

Investigación Personal Publicaciones Otros

 

Publicaciones

Año 2018

  • García-Sanz P and Moratalla R. The importance of colesterol accumulation in Parkinson’s disease, Mov Disord. 2018, DOI 10.1002/mds.27251, IF=7.01
  • García-Sanz P, Orgaz L, Fuentes JM, Mir P, Vicario C and Moratalla R. Cholesterol and multilamellar bodies: Lyosomal dysfunction in GBA-Parkinson disease. Autophagy 2018, DOI 10.1080/15548627.2018.1427396, IF=8.01

Año 2017

  • Solís O, Garcia-Montes JR, González-Granillo A, Xu M, Moratalla R. Dopamine D3 receptor modulates L-DOPA-induced dyskinesia by targeting D1 receptor-mediated striatal signaling. Cereb Cortex. 2017. 27: 435–446. IF=8.66
  • Moratalla R, Khairnar A, Simola N, Granado N, García-Montes JR, Porceddu PF, Tizabi Y, Costa G, Morelli M. Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms. Prog Neurobiol. 2017. 155:149-170, IF=9.99
  • García-Sanz P, Mirasierra M, Moratalla R, Vallejo M. Embryonic defence mechanisms against glucose-dependent oxidative stress require enhanced expression of Alx3 to prevent malformations during diabetic pregnancy. Scientific Reports. 2017. 7:389. IF=5.22
  • Solís O, Garcia-Montes JR, Garcia-Sanz P, Herranz AS, Asensio MA, Kang G, Hiroi N, Moratalla R. Human COMT over-expression confers a heightened susceptibility to dyskinesia in mice. Neurobiology of Disease. 2017. 102: 133-139 IF=4.85
  • F Hernández L, Castela I, Ruiz-DeDiego I, Obeso JA, Moratalla R. Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease. Mov Disord. 2017. 32: 530-537. IF=7.01
  • García-Sanz P, Orgaz L, Bueno-Gil G, Espadas I, Rodríguez-Traver E, Kulisevsky J, Gutierrez A, Dávila JC, González-Polo RA, Fuentes JM, Mir P, Vicario C, Moratalla R. N370S-GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease. Mov Disord. 2017 doi: 10.1002/mds.27119. IF=7.01

Año 2016

  • Suarez LM, Solis O, Aguado C, Lujan R, Moratalla R. L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia. Cereb Cortex.2016. IF=8.66
  • Rodríguez-Traver E, Solís O, Díaz-Guerra E, Ortiz Ó, Vergaño-Vera E, Méndez-Gómez HR, García-Sanz P, Moratalla R, Vicario-Abejón C. Role of nurr1 in the generation and differentiation of dopaminergic neurons from stem cells. Neurotox Res. 2016. 30:14-31. doi: 10.1007/s12640-015-9586-0 IF=3.538
  • Solís O, García-Sanz P, Herranz AS, Asensio MJ, Moratalla R. L-DOPA reverses the increased free amino acids tissue levels induced by dopamine depletion and rises GABA and tyrosine in the striatum. Neurotox Res. 2016. 30:67-75. doi: 10.1007/s12640-016-9612-x. IF=3.538
  • Mendieta L, Granado N, Aguilera J, Tizabi Y, Moratalla R. Fragment C Domain of Tetanus Toxin Mitigates Methamphetamine Neurotoxicity and Its Motor Consequences in Mice. Int J Neuropsychopharmacol. 2016. pii: pyw021 IF=4.33

Año 2015

  • Ruiz-DeDiego I, Mellstrom B, Vallejo M, Naranjo JR, Moratalla R. Activation of DREAM (downstream regulatory element antagonistic modulator), a calcium-binding protein, reduces L-DOPA-induced dyskinesias in mice. Biol Psychiatry. 2015. 77:95-105. IF=10.255
  • Solis O, Espadas I, Del-Bel EA, Moratalla R. Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(-/-) aphakia mice. Neurobiol Dis. 2015. 73:49-59. IF=5.078
  • Vergaño-Vera E, Díaz-Guerra E, Rodríguez-Traver E, Méndez-Gómez HR, Solís O, Pignatelli J, Pickel J, Lee SH, Moratalla R, Vicario-Abejón C. Nurr1 blocks the mitogenic effect of FGF-2 and EGF, inducing olfactory bulb neural stem cells to adopt dopaminergic and dopaminergic-GABAergic neuronal phenotypes. Dev Neurobiol. 2015. 75:823-41. IF=3.370
  • Carmena A, Granado N, Ares-Santos S, Alberquilla S, Tizabi Y, Moratalla R. Methamphetamine-induced toxicity in indusium griseum of mice is associated with astro- and microgliosis. Neurotox Res. 2015. 27:209-16. IF= 3.538
  • Castro-Hernández J, Afonso-Oramas D, Cruz-Muros I, Salas-Hernández J, Barroso-Chinea P, Moratalla R, Millan MJ, González-Hernández T. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake. Neurobiol Dis. 2015. 74:325-35. IF= 5.078
  • Ruiz-DeDiego I, Naranjo JR, Hervé D, Moratalla R. Dopaminergic regulation of olfactory type G-protein α subunit expression in the striatum. Mov Disord. 2015. 30:1039-49. IF= 5.680
  • Martín R, Bajo-Grañeras R, Moratalla R, Perea G, Araque A. Circuit-specific signaling in astrocyte-neuron networks in basal ganglia pathways. Science. 2015. 349:730-734. IF=33.61

Año 2014

  • Suárez LM, Solís O, Caramés JM, Taravini IR, Solís JM, Murer MG, Moratalla R. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice. Biol Psychiatry. 2014. 75:711-22. IF=10.255
  • Urrutia A, Granado N, Gutierrez-Lopez MD, Moratalla R, O'Shea E, Colado MI. The JNK inhibitor, SP600125, potentiates the glial response and cell death induced by methamphetamine in the mouse striatum. Int J Neuropsychopharmacol. 2014. 17:235-46. IF=4.009
  • Gonzalez-Aparicio R and Moratalla R. Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease. Neurobiol Dis. 2014. 62:416-25. IF=5.078
  • Ares-Santos S, Granado N, Espadas I, Martinez-Murillo R, Moratalla R. Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining. Neuropsychopharmacology. 2014. 39:1066-80. IF=7.048
  • Granado N, Ares-Santos S, Moratalla R. D1 but not D4 dopamine receptors are critical for MDMA-induced neurotoxicity in mice. Neurotox Res. 2014. 25:100-9. IF=3.538
  • Shen HY, Canas PM, Garcia-Sanz P, Lan JQ, Boison D, Moratalla R, Cunha RA, Chen JF. Adenosine A2A receptor in striatal glutamatergic terminal and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylation. PLoS One. 2013. 8:e80902. IF=3.534
  • Villar-Cheda B, Dominguez-Meijide A, Valenzuela R, Granado N, Moratalla R, Labandeira-Garcia JL. Aging-related dysregulation of dopamine and angiotensin receptor interaction. Neurobiol Aging. 2014. 35:1726-38. IF= 5.013
  • Heumann R, Moratalla R, Herrero MT, Chakrabarty K, Drucker-Colín R, Garcia-Montes JR, Simola N, Morelli M. Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions. J Neurochem. 2014. 130:472-89. IF=4.281

Año 2013

  • Suárez LM, Solís O, Caramés JM, Taravini IR, Solís JM, Murer MG, Moratalla R. L-DOPA Treatment Selectively Restores Spine Density in Dopamine Receptor D2-Expressing Projection Neurons in Dyskinetic Mice. Biol Psychiatry. 2013 Jun 12. pii: S0006-3223(13)00416-2. doi: 10.1016/j.biopsych.2013.05.006. IF=9.24
  • González-Aparicio R, Moratalla R.Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease. Neurobiol Dis. 2014 Feb;62:416-25. doi: 10.1016/j.nbd.2013.10.008. IF=5.63
  • Shen HY, Canas PM, Garcia-Sanz P, Lan JQ, Boison D, Moratalla R, Cunha RA, Chen JF. Adenosine A2A Receptors in Striatal Glutamatergic Terminals and GABAergic Neurons Oppositely Modulate Psychostimulant Action and DARPP-32 Phosphorylation. PLoS One. 2013 Nov 28;8(11):e80902. doi: 10.1371/journal.pone.0080902. eCollection 2013. IF=4,09
  • López-Jiménez A, Walter NA, Giné E, Santos Á, Echeverry-Alzate V, Bühler KM, Olmos P, Giezendanner S, Moratalla R, Montoliu L, Buck KJ, López-Moreno JA. A spontaneous deletion of α-synuclein is associated with an increase in CB1 mRNA transcript and receptor expression in the hippocampus and amygdala: effects on alcohol consumption. Synapse. 2013 Jun;67(6):280-9. doi: 10.1002/syn.21639. IF=2.95
  • Ares-Santos S, Granado N, Moratalla R.The role of dopamine receptors in the neurotoxicity of methamphetamine. J Intern Med. 2013 May;273(5):437-53. doi: 10.1111/joim.12049. Review. IF=5.48
  • Granado N, Ares-Santos S, Moratalla R. (2013) Methamphetamine and Parkinson's disease. Parkinsons Dis.;2013:308052. doi: 10.1155/2013/308052. Epub 2013 Feb 7. IF=1.08
  • Peraile I, Granado N, Torres E, Gutiérrez-López MD, Moratalla R, Colado MI, O'Shea E. Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders. Psychopharmacology (Berl). 2013 Nov;230(1):125-35. doi: 10.1007/s00213-013-3142-5. IF=4,08
  • Hai-Ying S, Canas PM, Garcia-Sanz P, Boison D, Moratalla R, Cunha RA, Chen JF. (2013) Adenosine A2A receptor in striatal glutamatergic terminal and GABAergic neuron oppositely modulate psychostimulant action and DARPP-32 phosphorylation. PLoS One, en prensa IF=4.09
  • Suárez LM, Solís O, Caramés JM, Taravini IR, Solís JM, Murer MG, Moratalla R. (2013) L-DOPA treatment selectively restores spine density in D2R-expressing projection neurons in dyskinetic mice. Biological Psychiatry, aceptado (PBS-114848) IF=9.24
  • Gonzalez-Aparicio R, Moratalla R. (2013) Oleoylethanolamide reduces L-Dopa-induced dyskinesias via TRPV1 receptor in a mouse model of Parkinson´s Disease. Neuorol Dis,. IF=5.63
  • Urritia A, Granado N, Gutierrez-Lopez MD, Moratalla R, O'Shea E, Colado M. (2013) The JNK inhibitor, SP600125, potentiates the glial response and cell death induced by methamphetamine in the mouse striatum. Int J Neuropsychopharmacol, en prensa. IF=5.64
  • Ares-Santos S, Granado N, Espadas I, Martinez-Murillo R, Moratalla R. Methamphetamine Causes Degeneration of Dopamine Cell Bodies and Terminals of the Nigrostriatal Pathway Evidenced by Silver Staining. Neuropsychopharmacology. 2013 Oct 30. doi: 10.1038/npp.2013.307. [Epub ahead of print] IF=8.67

Año 2012

  • Ares-Santos S, Granado N, Oliva I, O'Shea E, Martin ED, Colado MI, Moratalla R. (2012) Dopamine D(1) receptor deletion strongly reduces neurotoxic effects of methamphetamine. Neurobiol Dis. 45:810-820 IF=5.63
  • Madronal N, Gruart A, Valverde O, Espadas I, Moratalla R, Delgado-Garcia JM. (2012) Involvement of cannabinoid CB1 receptor in associative learning and in hippocampal CA3-CA1 synaptic plasticity. Cerebral Cortex; 22:550-556 IF=6.84
  • Espadas I, Darmopil S, Vergaño-Vera E, Ortiz O, Oliva I, Vicario-Abejón C, Martín ED, Moratalla R. (2012) L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: Insights into regulation and function. Neurobiol Dis.; 48:271-81 IF=5.63
  • Busceti CL, Bucci D, Molinaro G, Di Pietro P, Zangrandi L, Gradini R, Moratalla R, Battaglia G, Bruno V, Nicoletti F, Fornai F. (2012) Lack or inhibition of dopaminergic stimulation induces a development increase of striatal tyrosine hydroxylase-positive interneurons. PLoS One;7:e44025. doi: 10.1371/journal.pone.0044025. Epub 2012 Sep 18. IF=4.09

Año 2011

Año 2010

  • Granado N, Ares-Santos S, O'Shea E, Vicario-Abejón C, Colado MI, Moratalla R. (2010). Pubmed_DefaultReportPanel.Pubmed_RVDocSum" Selective Vulnerability in Striosomes and in the Nigrostriatal Dopaminergic Pathway After Methamphetamine Administration: Early Loss of TH in Striosomes After Methamphetamine. Neurotox Res., 18: 48-58. IF=3,02
  • Ramiro-Fuentes S, Ortiz O, Moratalla R, and E Fernandez-Espejo. (2010) Intra-accumbal rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo CB1R silencing: critical role for glutamate receptors. Neuroscience, 167:205-215. IF=3,22
  • Gramage E, Rossi L, Granado N, Moratalla R, Herradón G. (2010) Genetic inactivation of pleiotrophin triggers amphetamine-induced cell loss in the substantia nigra and enhances amphetamine neurotoxicity in the striatum. Neuroscience, 170: 308-316. IF=3,22
  • Ortiz O, Delgado-García JM, Espadas I, Dreyer JL, Bahí A, Trullas R, Gruart A and R Moratalla. (2010) Associative learning and CA3-CA1 synaptic plasticity are impaired in D1R null mice and hippocampal siRNA silenced D1R mice. J Neurosci, 30:12288-12300, IF= 7,8

Publicaciones mas relevantes

  • Ares-Santos S, Granado N, Espadas I, Martinez-Murillo R, Moratalla R. Methamphetamine Causes Degeneration of Dopamine Cell Bodies and Terminals of the Nigrostriatal Pathway Evidenced by Silver Staining. Neuropsychopharmacology. 2013 Oct 30. doi: 10.1038/npp.2013.307. [Epub ahead of print] IF=8.67
  • Suárez LM, Solís O, Caramés JM, Taravini IR, Solís JM, Murer MG, Moratalla R. L-DOPA Treatment Selectively Restores Spine Density in Dopamine Receptor D2-Expressing Projection Neurons in Dyskinetic Mice. Biol Psychiatry. 2013 Jun 12. pii: S0006-3223(13)00416-2. doi: 10.1016/j.biopsych.2013.05.006. IF=9.24
  • Madronal N, Gruart A, Valverde O, Espadas I, Moratalla R, Delgado-Garcia JM. (2012) Involvement of cannabinoid CB1 receptor in associative learning and in hippocampal CA3-CA1 synaptic plasticity. Cerebral Cortex, 22:550-556 IF=6.84
  • Ortiz O, Delgado-García JM, Espadas I, Dreyer JL, Bahí A, Trullas R, Gruart A and R Moratalla. (2010) Associative learning and CA3-CA1 synaptic plasticity are impaired in D1R null mice and hippocampal siRNA silenced D1R mice. J Neurosci, 30:12288-12300, IF= 7,8
  • Darmopil S, Martín AB, Ruiz de Diego I, Ares S and Moratalla R. (2009) Genetic inactivation of dopamine D1 receptors, but not D2 receptors, inhibits dyskinesia and histone phosphorylation induced by L-DOPA. Biol Psychiatry. 66:603-613. IF= 8,9
  • Martín AB, Fernández-Espejo E, Ferrer B, Gorriti MA, Navarro M, Rodríguez de Fonseca F and Moratalla R. (2008) Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacol, 33:1667-1679. IF= 6,84
  • Granado N, Ortiz, O, Suarez LM, Martín E, Ceña V and Solís JM and Moratalla R. (2008) D1 but not D5 dopamine receptors are critical for LTP, spatial learning, and LTP-Induced arc and zif268 expression in the hippocampus. Cerebral Cortex, 18:1-12. IF= 6,5
  • Carriba P, Justinova Z, Ortiz O, Patkar K, Woods AS, Hope BT, Canela E, Lluis C, Goldberg S, Moratalla R, Franco R and Ferré S. (2007) Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate motor effects of cannabinoides. Neuropsychopharmacol, 32:2249-59. Contribución equivalente, IF= 6,2
  • Pavón N, Martín AB, Mendialdua A and R. Moratalla. (2006) ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Biol Psychiatry, 59, 64-74. IF= 8,67
  • Grande, C., Zhu, H., Martín, A.B., Lee, M., Ortiz, O., Hiroi, N., Moratalla, R. (2004) Chronic treatment with atypical neuroleptics induces striosomal FosB/DeltaFosB expression in rats. Biol. Psychiatry 2004. 55:457-463.
  • Centonze D, Grande C, Usiello A, Martín AB, Gubellini P, Pisani A, Bernardi G, Borrelli E, Moratalla R and Calabresi P. (2003) Receptor Subtypes Involved in the Pre- and Postsynaptic Actions of Dopamine on Large Aspiny and Fast-Spiking Striatal Interneurons, J Neurosci, 23:6245-54. Contribución equivalente IF= 8,18
  • Centonze D, Grande C, Saulle E, Martín AB, Gubellini P, Pavón N, Pisani A, Bernardi G, Moratalla R, and Calabresi P. (2003) Distinct roles of dopamine D1 and D5 receptors in motor activity and striatal synaptic plasticity. J Neurosci, 23: 8506-8512. Contribución equivalente IF= 8,18
  • Fredduzzi S, Moratalla R, Monopoli A, Cuellar B, Xu K, Ongini E, Impagnatiello F, Schwarzschild MA and Chen J-F. (2002) Persistent behavioral sensitization to chronic L-dopa requires A2A adenosine receptors. J Neurosci, 22, 1054-1062. IF= 8,18
  • Froger N., Gardier A.M., Moratalla R., Alberti I., Lena I., De Felipe C., Rupniak N.M.J., Hunt S.P., Jacquot C., Hamon M. and Lanfumey L. (2001) 5-HT1A autoreceptor adaptative changes in substance P (NK1) receptor knock out mice mimic antidepressant-induced desensitization. J Neurosci, 21: 8188-8197. IF= 8,18
  • Chen J-F., Moratalla R., Impagnatiello F., Grandy D. K, B. Cuellar, M. Rubinstein, M. A. Beilstein+, E. Hackett , J. S. Fink, M J. Low, E. Ongini and M. A. Schwarzschild.(2001) Dispensable Role of D2 Dopamine Receptors in A2A Adenosine Receptor-Induced Behavioral and Cellular Responses as Revealed by A2A and D2 Receptor Knockout Mice. PNAS, 98: 1970-1975. IF= 10,9
  • Schwartz, P., Pérez-Villamil, P., Rivera, A., Moratalla, R. and Vallejo, M. (2000) IDX/PDX-1 regulates transcription of the somatostatin and glial fibrillary acidic protein genes in neural cells: Evidence for transient expression in developing brain. J. Biol. Chem, 275: 19106-19114. IF= 7,3
  • Chen, J.F., Huang Z., Ma J. Zhu J., Moratalla, R., Standaert, D.G., Moskowitz M., Fink, S and Shwarzschild, M.A.. “A2a adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. Journal of Neuroscience. 1999, 19: 9192-9200. IF= 8,96
  • Xu, M., Koeltzow, TE, Santiagi, GT, Moratalla, R., Cooper, DC., Hu, XT, White, NM, Graybiel AM White FJ and Tonegawa, S. “Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors”. Neuron; 1997, 19: 19837-848. IF= 15,82
  • Moratalla, R., Xu, M., Tonegawa, S. and Graybiel, A. (1996) Cellular responses to psychomotor stimulants and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. PNAS, 93: 14928-14933. IF= 10,24
  • Moratalla, R., Elibol, B., Vallejo, M. and Graybiel, A.M. (1996) Network-level changes in inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron, 17: 147-156. IF= 16,95
  • Xu, M., Moratalla, R., Gold, L. H., Hiroi, N., Koob, G. F., Graybiel, A. M. and Tonegawa, S. (1994) Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell, 79: 729-742. IF= 39,19
  • Xu, M., Hu, X.-T., Cooper, D. C., Moratalla, R., Graybiel, A. M., White, F. J., and Tonegawa, S. (1994) Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell, 79: 945-955. IF= 39,19
  • Moratalla, R., Vickers, E.A.. Robertson, H.A., Cochran, B.H. and Graybiel, A.M. (1993) Coordinate expression of c-fos and jun B in the rat striatum by cocaine. J Neurosci, 13: 423-433. IF= 8,04
  • Centonze D, Grande C, Usiello A, Martín AB, Gubellini P, Pisani A, Bernardi G, Borrelli E, Moratalla R and Calabresi P. (2003) Receptor Subtypes Involved in the Pre- and Postsynaptic Actions of Dopamine on Large Aspiny and Fast-Spiking Striatal Interneurons, J Neurosci, 23:6245-54. Contribución equivalente IF= 8,18
  • Moratalla, R., Robertson, H.A., and Graybiel, A.M. (1992) Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum. J Neurosci, 12: 2609 2622. IF= 7,16Moratalla, R., Quinn ,B., DeLanney, L.E., Langston, J.W. and Graybiel, A.M. (1992) Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of MPTP. PNAS, 89: 3859-3863. IF= 10,48
  • Graybiel, A.M., Moratalla, R. and Robertson, H.A. (1990) Amphetamine and cocaine induce transcription of the proto-oncogene c-fos in striosome-matrix and limbic subdivisions of the striatum. PNAS, 87: 6912 6916. IF= 9,94
  • Graybiel, A.M. and Moratalla, R. (1989) Dopamine uptake sites in the striatum are distributed differentially in strisome and matrix compartments. PNAS, 86: 9020-9024. IF= 9,97

Cubiertas de publicaciones relevantes:


Inicio Instituto Cajal Departamentos Personal Publicaciones Noticias Biblioteca Enlaces Acceso intranet Contacto Politica de privacidad y avisos legales  
Av. Doctor Arce, 37. 28002 Madrid - España • Tel.: +34 915854750 • Fax.: +34 915854754 • Síguenos en Twitter